AssureRx Updates PGx Test for Assessing Best Responders to Psychotropic Drugs
January 18, 2012
AssureRx Updates PGx Test for Assessing Best Responders to Psychotropic Drugs
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Medco to Evaluate Clinical Utility of AssureRx's PGx Test in Guiding Psychiatric Treatment
May 18, 2011 / Pharmacogenomics Reporter - Diamond Healthcare to Offer AssureRx's PGx Test to Guide Antipsychotic Therapy
September 29, 2010 / Pharmacogenomics Reporter - CDC Workgroup Publishes Guidelines for NGS-based Clinical Tests
November 28, 2012 / Clinical Sequencing News - Following Merger, Express Scripts May Cut Back Medco's Personalized Medicine Programs
May 9, 2012 / Pharmacogenomics Reporter - Clinical Labs Must Navigate Tricky Regulatory Landscape for RUO Sequencing Products
April 11, 2012 / Clinical Sequencing News